vaspin调控糖尿病炎症通路及苦酸通调法的干预机制研究

《vaspin调控糖尿病炎症通路及苦酸通调法的干预机制研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、学校代号10199学号20111506002博士学位论文Vaspin调控糖尿病炎症通路及苦酸通调法的干预机制研究TheresearchofthemechanismofVaspinandthemethodofKuSuanTongTiaoinregulatinginflammatorypathwayindiabetesmellitus学位申请人米佳导师姓名职称南征教授专业名称中医内科学研究方向中医药防治消渴合并症的研究培养方式全日制申请学位类型科学学位论文提交日期2015年4月分类号密级ＵＤＣ编号博±学位论文Ｖａｓｐｉｎ调控

2、糖尿病炎症通路及苦酸通调法的干顽机制研究ＴｈｅｒｅｓｅａｒｃｈｏｆｔｈｅｍｅｃｈａｎｉｓｍｏｆＶａｓｉｎｐａｎｄｔｈｅｍｅｔｈｏｄｏｆＫｕＳｕａｎＴｏｎＴｉａｏｉｎｇｒｅｇｕｌａｔｉｎｇｉｎ打ａｍｍａｔｏｒａｔｈｗａｉｎｙｐｙｄｉａｂｅｔｅｓｍｅｌｌｉｔｕｓ米佳指导教师姓名：南征教授（长春中医药大学）申请学位级别：博±专业名称：中医内科学硏究方向：中医药防治消渴合并症的硏究论文提交日期：２０１５年４月论文答辩日期：２０１５年６月学位授予单位：长春中医药大学提交

3、确认：作者签名导师签名：尸＾＾＾￡＝＿＿／长春中医药大学学位论文原创性声明本人郑重声明：巧呈交的学位论文下，独立进行研究工作巧取得的成果。，是个人在导师的指导除文中已经特别加Ｕ注明引巧的内容外，本论文不含任何其他个人或集体已经发表或撰写过的作品成果。对本文的研究做出重要贡献的个人和集体，均已在文中明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。学位论文作者签名？月曰＞／了年关于学位论文知识产权归属的声明本人郑重声明：所呈交的学位论文，是本人在导师指导下自选课题或导师承担的国家立项资助一的计划

4、课题的部分，系本人在导师指导和资助下独立进行研究工作所取将的成果，知识产权归属权为长春中医药大学和本人导师所有。恃此声明，本声明的一切法律责任由本人承担。论文作者黎＾么指导教师答《方？化月曰＾关于学位论文使用授权的声明—论本人完全了解长春中医药大学有关保留使用学位论文的规定，同意学校保留并向有关机构送交文的复印件和电子版，允许被查阅和借阅。本人授权长春中医药大学可１＾１将本学位论文的全部或部分内容编人有关数据库进行检索，可１＾：／采用影印、缩印或其他复印手段保存和汇编本学位论文。（保密论文在解密后应遵守此规定）

5、论文作者巧名指导＂教师综名年曰长春中医药大学2015届博士学位论文目录目录中文摘要································································································1英文摘要································································································3英文缩略语···························

6、··································································5前言································································································7文献综述································································································8一2型糖尿病胰岛素

7、抵抗的中医药研究进展·················································81祖国医学对2型糖尿病胰岛素抵抗病名的认识···········································82祖国医学对2型糖尿病胰岛素抵抗病因病机的认识·····································93祖国医对2型糖尿病胰岛素抵抗辨证论治的研究进展··································154祖国医药防治2型糖尿病胰岛素抵抗专方专法的研究进展····

8、························175存在的问题与展望·································